KBP Biosciences Co., Ltd.
Records under this name other than the patents KBP Biosciences Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 8 of 8 · Back to KBP Biosciences Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,293,895 | Carbapenem derivatives Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,318,716 | Carbapenem derivatives Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,946,279 | Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist Formerly held In force · High confidence | In force | High confidence | |
| US 9,468,635 | Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist Formerly held In force · High confidence | In force | High confidence | |
| US 10,322,132 | Prevention or treatment of uratic or gouty diseases Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,806,344 | Pharmaceutical Composition Comprising Mineralocorticoid Receptor Antagonist and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,809,589 | Crystal Form of Compound Used as Mineralocorticoid Receptor Antagonist and Preparation Method Therefor Formerly held Lapsed on the fee record Ended Nov 7, 2025 · High confidence | Lapsed on the fee record | Ended Nov 7, 2025 | High confidence |
| US 9,233,098 | Nitrogen-containing fused ring compounds as CRTH2 antagonists Lapsed on the fee record Ended Jan 12, 2024 · USPTO record | Lapsed on the fee record | Ended Jan 12, 2024 | USPTO record |